סרטיקן ® 0.25 מ"ג טבליות מסיסות

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

EVEROLIMUS 0.25 MG

Dostopno od:

NOVARTIS PHARMA SERVICES AG

Koda artikla:

L04AA18

Farmacevtska oblika:

TABLETS DISPERSIBLE

Pot uporabe:

PER OS

Izdeluje:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapevtska skupina:

EVEROLIMUS

Terapevtske indikacije:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Datum dovoljenje:

2010-02-01